SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Price-to-earnings ratio
5Y CAGR
-24.3%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.44 | +628.7% |
| 2024 | -1.03 | -14.3% |
| 2023 | -0.90 | +34.3% |
| 2022 | -1.37 | +93.1% |
| 2021 | -19.80 | -190.3% |
| 2020 | 21.93 | +144.7% |
| 2019 | -49.10 | - |